Remove 2024 Remove Biopharmaceuticals Remove Collaboration
article thumbnail

BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies

Frost & Sullivan

BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies. times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production.

article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

Top 12 Biopharma Thought Leaders in 2024 1. His career highlights include igniting US reimbursement pathways for Prescription Digital Therapeutics (PDT), pioneering value-based collaboration between payers and manufacturers, and introducing groundbreaking biotech and healthtech solutions.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services

Frost & Sullivan

San Antonio, TX — 24th July, 2024 — Frost & Sullivan has recognized Aragen Life Sciences, a world-class contract research, development, and manufacturing organization (CRDMO), with the 2024 Global Customer Value Leadership Award. Visit www.aragen.com for more details. The post Aragen Life Sciences Ltd.

article thumbnail

ASCO 2024 Round Up: Advancements in Biomarker-Driven Medicines, Cancer Vaccines, and AI Applications Paving the Way for Expansion of Precision Oncology

Frost & Sullivan

The sessions of the American Society of Clinical Oncology ( ASCO ) 2024 conference focused on this year’s theme – The Art and Science of Cancer Care: From comfort to cure. Merck and Moderna officially disclosed the three-year results from a phase IIb study of their collaborative cancer vaccine for resected melanoma in ASCO.

article thumbnail

J.P Morgan 2024: Insights, Trends, and Tools for Maximizing your Experience

LaVoie Health Science Blog

Looking ahead to 2024, professionals worldwide are eagerly gearing up for one of the most anticipated events in the financial calendar—the J.P. Morgan 2024 experience. Keep an eye on evolving partnership models and consider how your business can leverage these collaborative opportunities. Morgan Healthcare Conference.

article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

The Drug, Chemical & Associated Technologies Association (DCAT) 2024 event held in New York City on March 18-21 showcased product and technology innovations and capabilities presentations by member companies. in January 2024 further enhanced its portfolio of complex drug-device combination products.